Monmouth Junction, NJ – January 14, 2026 – TheWell Bioscience is proud to announce the commercial launch of its new RocketCell™ product line, introducing two cutting-edge solutions for stem cell research: the RocketCell™ 3D iPSC Xeno-Free Complete Growth Kit and the RocketCell™ iPSC Xeno-Free Growth Medium. These products are engineered to resolve critical bottlenecks in […]
Monmouth Junction, NJ and Tokyo, Japan — January 7, 2026 — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, […]
Xeno-free VitroGel® system supports breast cancer prevention studies.
TheWell Bioscience 2025: A Breakthrough Year in 3D Cell Culture Innovation 2025 was a transformative year for TheWell Bioscience, marked by strong execution across innovation, market expansion, and community engagement. Through pioneering product launches, we established the industry’s most comprehensive end-to-end xeno-free 3D cell culture platform—positioning the company for sustained growth in advanced translational research […]
There is no excerpt because this is a protected post.
SfN Neuroscience 2025 Recap: A Week of Innovation, Collaboration, and Discovery
VitroGel® 3D enables precise chemogenetic targeting of carotid body cells to uncover metabolic function. During intense exercise, our bodies have a “ceiling” for oxygen consumption, known as peak oxygen uptake (VO₂ peak), which is a key determinant of athletic endurance. For decades, scientists have known that a tiny organ in the neck, the carotid body, […]
VitroGel® MSC overcomes the limitations of 2D and microcarrier systems by delivering a reproducible, scalable, and functional workflow for MSC biomanufacturing, from expansion to genetic engineering. The production of mesenchymal stem cells (MSCs) at a clinical scale faces persistent challenges. Traditional 2D culture systems and microcarriers are limited by scalability, high costs, and difficulties in […]
Abstract: Human induced pluripotent stem cells (iPSCs) offer a powerful starting point to study the molecular dynamics of the developing nervous system. Further, they provide an invaluable tool for developing patient-specific models to study the disease process. Therefore, optimizing their growth in a defined, native 3D state is of paramount importance to both guide and […]
